SOSoeren Ocvirk

Soeren Ocvirk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Soeren Ocvirk has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endogenous Gdf15 activation limits adiposity and increases fecal energy excretion in mice

    by Maximilian Kleinert, Sarah Engelbeen, Kornelia Johann, Casper Sigvardsen, Franziska Sörgel, Alina Blenninger, Christopher Bishop, Christian Voldstedlund, Soeren Ocvirk, Joan Pasano, et al.

    Growth differentiation factor 15 (GDF15) is an emerging target for obesity, but the effects of sustained physiological increases in endogenous GDF15 remain unclear. Here we use muscle-targeted CRISPR activation to elevate endogenous Gdf15 expression in mice. High-physiological circulating GDF15 prevents diet-induced obesity by limiting fat accumulation while preserving lean mass. This protection requires the endogenous Gdf15 locus and GFRAL signaling, without a detectable increase in energy expenditure. Alongside modest, inconsistent reductions in food intake, Gdf15 activation increases fecal energy excretion, accompanied by gut microbiota remodeling and altered ileal transcriptional programs. In mice with established obesity, Gdf15 activation reduces adiposity and increases fecal energy excretion without a detectable reduction in food intake. These findings identify fecal energy excretion as a GDF15-regulated component of energy balance and support a role for endogenous GDF15 beyond appetite regulation.

  • Open Access

    Endogenous Gdf15 induction promotes obesity resistance by augmenting energy excretion

    by Maximilian Kleinert, Sarah Engelbeen, Kornelia Johann, Casper Sigvardsen, Franziska Sörgel, Alina Blenninger, Christopher Bishop, Christian Voldstedlund, Soeren Ocvirk, Joan Pasano, et al.

    Growth differentiation factor 15 (GDF15) is a hormone-like factor that has emerged as a potential therapeutic treatment of obesity. Pharmacological studies have shown that high, supraphysiological doses of recombinant, mature human GDF15 decrease food intake in obese mice; yet, the metabolic impact of physiological elevations in endogenous GDF15 are unknown. Here, we delivered CRISPR activation (CRISPRa) via muscle-targeting viral vectors in mice to upregulate endogenous Gdf15 expression, resulting in a five- to eight-fold increase in circulating GDF15 levels, comparable to that seen after prolonged exercise or with aging. This physiological elevation in circulating GDF15 conferred resistance to diet-induced obesity by selectively preventing fat mass accumulation without detrimental impact on lean mass and in the absence of aversion-like behavior typically observed with high GDF15 levels. The anti-obesity effect was Gdf15 locus-specific, dependent on the GDF15-receptor, GFRAL, and occurred without changes in energy expenditure of mice. Instead, elevated circulating GDF15 was linked to a reduction in food intake coupled with increased fecal energy loss, a distinct clustering of gut microbiota composition associated with higher microbial diversity, and transcriptional reprogramming of the ileal epithelium towards higher barrier function and antimicrobial defense. In conclusion, we show that in an obesogenic environment, endogenous GDF15 selectively prevents fat accumulation, spares lean mass and regulates energy assimilation with clear consequences for the gut microbial milieu and whole-body energy balance.

  • 1156 CAN HIGH FIBER SUPPLEMENTS REDUCE THE EXCESS RISK OF COLON CANCER IN ALASKA NATIVE PEOPLE? PRELIMINARY FINDINGS IN THE ALASKA FIBER INTERVENTION RESEARCH STUDY (FIRST)

    by B.L. Eberhart, Miriam R. Perez, Annette Wilson, Kathryn R. Koller, Flora Lee, Priya Iyer, Gretchen Day, Soren Ocvirk, Ziyu Huang, Timothy Thomas, et al.

  • Diet and the Human Gut Microbiome: An International Review

    by Annette S. Wilson, Kathryn R. Koller, Matsepo C. Ramaboli, Lucky T. Nesengani, Soeren Ocvirk, Caixia Chen, Christie A. Flanagan, Flora R. Sapp, Zoe T. Merritt, Faheem Bhatti, et al.

    This review summarizes the key results of recently published studies on the effects of dietary change and nutritional intervention on the human microbiome from around the world, focusing on the USA, Canada, Europe, Asia, and Africa. It first explores mechanisms that might explain the ability of fiber-rich foods to suppress the incidence and mortality from westernized diseases, notably cancers of the colon, breast, liver, cardiovascular, infectious, and respiratory diseases, diabetes, and obesity (O’Keefe in Lancet Gastroenterol Hepatol 4(12):984–996, 2019; Am J Clin Nutr 110:265–266, 2019). It summarizes studies from Africa which suggest that disturbance of the colonic microbiome may exacerbate chronic malnutrition and growth failure in impoverished communities and highlights the importance of breast feeding. The American section discusses the role of the microbiome in the swelling population of patients with obesity and type 2 diabetes and examines the effects of race, ethnicity, geography, and climate on microbial diversity and metabolism. The studies from Europe and Asia extoll the benefits of whole foods and plant-based diets. The Asian studies examine the worrying changes from low-fat, high-carbohydrate diets to high-fat, low-carbohydrate ones and the increasing appearance of westernized diseases as in Africa and documents the ability of high-fiber traditional Chinese diets to reverse type 2 diabetes and control weight loss. In conclusion, most of the studies reviewed demonstrate clear changes in microbe abundances and in the production of fermentation products, such as short-chain fatty acids and phytochemicals following dietary change, but the significance of the microbiota changes to human health, with the possible exception of the stimulation of butyrogenic taxa by fiber-rich foods, is generally implied and not measured. Further studies are needed to determine how these changes in microbiota composition and metabolism can improve our health and be used to prevent and treat disease.


  • A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer

    by Soeren Ocvirk, Annette S Wilson, Joram M Posma, Jia V Li, Kathryn R Koller, Gretchen M Day, Christie A Flanagan, Jill Evon Otto, Pam E Sacco, Frank D Sacco, et al.

    Alaska Native (AN) people have the world's highest recorded incidence of sporadic colorectal cancer (CRC) (∼91:100,000), whereas rural African (RA) people have the lowest risk (1H-NMR spectroscopy was complemented with targeted quantification of fecal SCFAs, bile acids, and functional microbial genes. Adenomatous polyps were detected in 16 of 32 AN participants, but not found in RA participants. The AN diet contained higher proportions of fat and animal protein and less fiber. AN fecal microbiota showed a compositional predominance of Blautia and Lachnoclostridium, higher microbial capacity for bile acid conversion, and low abundance of some species involved in saccharolytic fermentation (e.g., Prevotellaceae, Ruminococcaceae), but no significant lack of butyrogenic bacteria. Significantly lower concentrations of tumor-suppressive butyrate (22.5 ± 3.1 compared with 47.2 ± 7.3 SEM µmol/g) coincided with significantly higher concentrations of tumor-promoting deoxycholic acid (26.7 ± 4.2 compared with 11 ± 1.9 µmol/g) in AN fecal samples. AN participants had lower quantities of fecal/urinary metabolites than RA participants and metabolite profiles correlated with the abundance of distinct microbial genera in feces. The main microbial and metabolic CRC-associated markers were not significantly altered in AN participants with adenomatous polyps. The low-fiber, high-fat diet of AN people and exposure to carcinogens derived from diet or environment are associated with a tumor-promoting colonic milieu as reflected by the high rates of adenomatous polyps in AN participants.


  • Fiber, Fat, and Colorectal Cancer: New Insight into Modifiable Dietary Risk Factors

    by Soeren Ocvirk, Annette S. Wilson, Corynn N. Appolonia, Timothy K. Thomas, Stephen J. D. O’kEefe

    To review recent data on the role and interactions of fiber and fat as dietary risk factors associated with colorectal cancer (CRC) risk in humans.


  • Differences in Fecal Gut Microbiota, Short-Chain Fatty Acids and Bile Acids Link Colorectal Cancer Risk to Dietary Changes Associated with Urbanization Among Zimbabweans

    by L. Katsidzira, S. Ocvirk, A. Wilson, J. Li, C. B. Mahachi, D. Soni, J. DeLany, J. K. Nicholson, E. G. Zoetendal, S. J. D. O’kEefe

    The incidence of colorectal cancer (CRC) is gradually rising in sub-Saharan Africa. This may be due to dietary changes associated with urbanization, which may induce tumor-promoting gut microbiota composition and function. We compared fecal microbiota composition and activity in 10 rural and 10 urban Zimbabweans for evidence of a differential CRC risk. Dietary intake was assessed by a food frequency questionnaire. Fecal microbiota composition, metabolomic profile, functional microbial genes were analyzed, and bile acids and short chain fatty acids quantified. Animal protein intake was higher among urban volunteers, but carbohydrate and fiber intake were similar. Bacteria related to Blautia obeum, Streptococcus bovis, and Subdoligranulum variabile were higher in urban residents, whereas bacteria related to Oscillospira guillermondii and Sporobacter termitidis were higher in rural volunteers. Fecal levels of primary bile acids, cholic acid, and chenodeoxycholic acid (P < 0.05), and secondary bile acids, deoxycholic acid (P < 0.05) and ursodeoxycholic acid (P < 0.001) were higher in urban residents. Fecal levels of acetate and propionate, but not butyrate, were higher in urban residents. The gut microbiota composition and activity among rural and urban Zimbabweans retain significant homogeneity (possibly due to retention of dietary fiber), but urban residents have subtle changes, which may indicate a higher CRC risk.


  • Influence of Bile Acids on Colorectal Cancer Risk: Potential Mechanisms Mediated by Diet-Gut Microbiota Interactions

    by Soeren Ocvirk, Stephen Jd O’kEefe

    Purpose of Review The purpose of this study is to review the evidence for the tumorigenic effects of food-stimulated bile acids on the colon and interaction with the gut microbiota. Recent Findings High-fat diets promote the hepatic synthesis of bile acids and increase their delivery to the colonic lumen. Here, they stimulate the growth and activity of 7α-dehydroxylating bacteria, which convert primary into secondary bile acids that show tumorigenic activity, especially deoxycholic acid (DCA). Fecal levels of secondary bile acids correlate with mucosal and metabolic markers of colorectal cancer (CRC) risk in high- and low-risk adult individuals and can be modified within a few weeks by dietary change. While gut bacteria regulate the bile acid pool via complex microbial biotransformation, bile acids alter the gut microbiota composition due to their antimicrobial properties. This mutual reaction induces altered bile acid pools and dysbiotic compositions of the gut microbiota that may show tumor-promoting activity of bile acids beyond their conversion to DCA. Summary Bile acids act as tumor promoters in the colon. Diet and the gut microbiota are most likely the key drivers that mediate and confer bile acid-associated tumorigenic activity. Bacterial conversion of bile acids in the colon has a significant impact on their tumorigenic activity, substantiating the hypothesis that diet affects CRC risk through its effects on colonic microbial metabolism.


  • Open Access

    Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels

    by Soeren Ocvirk, Irina G Sava, Isabella Lengfelder, Ilias Lagkouvardos, Natalie Steck, Jung H Roh, Sandrine Tchaptchet, Yinyin Bao, Jonathan J Hansen, Johannes Huebner, et al.

    The commensal Enterococcus faecalis is among the most common causes of nosocomial infections. Recent findings regarding increased abundance of enterococci in the intestinal microbiota of patients with inflammatory bowel diseases and induction of colitis in IL-10-deficient (IL-10-/-) mice put a new perspective on the contribution of E. faecalis to chronic intestinal inflammation. Based on the expression of virulence-related genes in the inflammatory milieu of IL-10-/- mice using RNA-sequencing analysis, we characterized the colitogenic role of two bacterial structures that substantially impact on E. faecalis virulence by different mechanisms: the enterococcal polysaccharide antigen and cell surface-associated lipoproteins. Germ-free wild type and IL-10-/- mice were monoassociated with E. faecalis wild type OG1RF or the respective isogenic mutants for 16 weeks. Intestinal tissue and mesenteric lymph nodes (MLN) were collected to characterize tissue pathology, loss of intestinal barrier function, bacterial adhesion to intestinal epithelium and immune cell activation. Bone marrow-derived dendritic cells (BMDC) were stimulated with bacterial lysates and E. faecalis virulence was additionally investigated in three invertebrate models. Colitogenic activity of wild type E. faecalis (OG1RF score: 7.2±1.2) in monoassociated IL-10-/- mice was partially impaired in E. faecalis lacking enterococcal polysaccharide antigen (ΔepaB score: 4.7±2.3; pE. faecalis deficient for lipoproteins (Δlgt score: 2.3±2.3; pE. faecalis mutants showed significantly impaired virulence in Galleria mellonella and Caenorhabditis elegans. Loss of E-cadherin in the epithelium was shown for all bacterial strains in inflamed IL-10-/- but not wild type mice. Inactivation of epaB in E. faecalis reduced microcolony and biofilm formation in vitro, altered bacterial adhesion to intestinal epithelium of germ-free Manduca sexta larvae and impaired penetration into the colonic mucus layer of IL-10-/- mice. Lipoprotein-deficient E. faecalis exhibited an impaired TLR2-mediated activation of BMDCs in vitro despite their ability to fully reactivate MLN cells as well as MLN-derived colitogenic T cells ex vivo. E. faecalis virulence factors accounting for bacterial adhesion to mucosal surfaces as well as intestinal barrier disruption partially contribute to colitogenic activity of E. faecalis. Beyond their well-known role in infections, cell surface-associated lipoproteins are essential structures for colitogenic activity of E. faecalis by mediating innate immune cell activation. Enterococcus faecalis is a commensal of the human intestinal core microbiota harboring several putative virulence factors, which highlight its role as opportunistic pathogen. This dualistic character is supported by recent evidence linking Enterococcus spp. to the pathogenesis of inflammatory bowel diseases (IBD). Although several studies suggest a crucial role for opportunistic pathogens in IBD pathogenesis targeting genetically susceptible individuals, the dynamic relationship between disease-relevant host compartments and specific bacterial structures able to trigger intestinal inflammation remain unclear. Here, we report that cell surface-associated lipoproteins and the enterococcal polysaccharide antigen, which are relevant for E. faecalis virulence in invertebrate infection models, but whose expression is minimally affected by the intestinal inflammatory milieu, exhibit colitogenic activity in a mouse model susceptible for chronic colitis. Bacterial lipoproteins trigger innate immune cell activation and are a critical prerequisite for E. faecalis-induced colitis. The enterococcal polysaccharide antigen mediates bacterial mucus penetration and adhesion to mucosal surfaces, promotes the formation of biofilm and contributes to E. faecalis colitogenic activity. Using E. faecalis as a model organism, we demonstrate that colitogenic activity of opportunistic pathogens can be assigned to specific bacterial structures, a finding that may help to identify the most essential steps in IBD-related microbe-host interactions.


  • Sa1752 Colitogenic Activity of Enterococcus Faecalis Requires Lipoprotein-Mediated Activation of Innate Immune Effector Functions in IL-10-/-Mice

    by Soeren Ocvirk, Irina Sava, Natalie Steck, Jung H. Roh, Sandrine Y. Tchaptchet, Jonathan J. Hansen, Johannes Huebner, Barbara E. Murray, Ryan B. Sartor, Dirk Haller